ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,622.85
      1.27%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aclaris Therapeutics Inc (ACRS)

      7. Aclaris Therapeutics Inc (ACRS) News

      ACRS

      Aclaris Therapeutics (ACRS)

      Aclaris Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ACRS
      DateTimeSourceHeadlineSymbolCompany
      11/14/20165:06PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ACRSAclaris Therapeutics Inc
      11/03/20168:36AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ACRSAclaris Therapeutics Inc
      11/03/20168:33AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRSAclaris Therapeutics Inc
      11/03/20167:36AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      11/03/20167:00AMGlobeNewswire Inc.Aclaris Therapeutics Reports Third Quarter 2016 Financial ResultsNASDAQ:ACRSAclaris Therapeutics Inc
      11/02/20164:16PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ACRSAclaris Therapeutics Inc
      11/02/20164:14PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ACRSAclaris Therapeutics Inc
      11/02/20164:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      10/31/20168:00AMGlobeNewswire Inc.Aclaris Therapeutics Submits Investigational New Drug Application for ATI-50001 to Treat Alopecia Universalis and Alopecia To...NASDAQ:ACRSAclaris Therapeutics Inc
      10/28/20164:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      10/28/20163:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      10/28/20168:00AMGlobeNewswire Inc.Aclaris Therapeutics Honored as One of the Best Places to Work in PennsylvaniaNASDAQ:ACRSAclaris Therapeutics Inc
      10/25/20168:00AMGlobeNewswire Inc.Aclaris Therapeutics to Announce Third Quarter 2016 Financial Results on November 3, 2016NASDAQ:ACRSAclaris Therapeutics Inc
      10/20/20164:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      10/19/20168:00AMGlobeNewswire Inc.New Observational Study Demonstrates Patient Impact of Seborrheic Keratosis, A Common, Undertreated Skin Condition Affecting ...NASDAQ:ACRSAclaris Therapeutics Inc
      10/06/20164:31PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRSAclaris Therapeutics Inc
      09/28/20166:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      09/19/20167:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      09/19/20167:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      09/19/20167:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      09/19/20167:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      09/19/20165:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      09/13/20168:57AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ACRSAclaris Therapeutics Inc
      09/13/20168:54AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      09/06/20168:00AMGlobeNewswire Inc.Aclaris Therapeutics to Present at the Morgan Stanley 2016 Healthcare ConferenceNASDAQ:ACRSAclaris Therapeutics Inc
      09/02/20166:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      09/02/20166:13PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ACRSAclaris Therapeutics Inc
      08/31/201611:10AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      08/29/20164:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      08/18/20167:30AMGlobeNewswire Inc.Aclaris Therapeutics Announces Positive Results in Phase 2 Clinical Trial of A-101 for Treatment of Common Warts  NASDAQ:ACRSAclaris Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ACRS